DeFronzo, R. A., Ferrannini, E., Schernthaner, G., Hantel, S., Elsasser, U., Lee, C., . . . Lund, S. S. (2018). Slope of change in HbA(1c) from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes. Endocrinol Diabetes Metab.
Chicago-стиль цитированияDeFronzo, Ralph A., Ele Ferrannini, Guntram Schernthaner, Stefan Hantel, Ulrich Elsasser, Christopher Lee, Thomas Hach, and Søren S. Lund. "Slope of Change in HbA(1c) From Baseline With Empagliflozin Compared With Sitagliptin or Glimepiride in Patients With Type 2 Diabetes." Endocrinol Diabetes Metab 2018.
MLA-цитированиеDeFronzo, Ralph A., et al. "Slope of Change in HbA(1c) From Baseline With Empagliflozin Compared With Sitagliptin or Glimepiride in Patients With Type 2 Diabetes." Endocrinol Diabetes Metab 2018.